Reuters logo
BRIEF-Galena Biopharma and Biovascular Inc reaffirm GALE-401 partnership
September 11, 2017 / 11:14 AM / 3 months ago

BRIEF-Galena Biopharma and Biovascular Inc reaffirm GALE-401 partnership

Sept 11 (Reuters) - Galena Biopharma Inc:

* Galena Biopharma and Biovascular Inc reaffirm GALE-401 partnership

* Galena Biopharma-‍working in conjunction with Sellas Life Sciences, co’s proposed merger candidate, Biovascular has withdrawn its notice of termination​

* Galena - Co, Biovascular amended license agreement to advance asset either through internal clinical development or by seeking licensing partner​

* Galena Biopharma Inc - co ‍has completed majority of work for initiation of a phase 3 trial in patients with essential thrombocythemia​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below